Table 3.
Outcomes at 30- and 180-day follow-up, total sample without heart failure
| Control (n = 163) | Intervention (n = 140) | p value | |
|---|---|---|---|
| Drug-related readmissions | |||
| Drug-related readmissions, no. | 46 | 23 | 0.03 |
| Certain (no. of individual patientsa) | 1 (1) | 0 (0) | |
| Probable (no. of individual patientsa) | 13 (12) | 7 (6) | |
| Possible (no. of individual patientsa) | 32 (20) | 16 (10) | |
| Patients readmitted because of DRP, no. (%) | 33 (20) | 15 (11) | 0.02 |
| Patients readmitted because of DRP within 30 days, no. (%) | 15 (9) | 4 (3) | 0.02 |
| Readmissions all causes | |||
| Patients readmitted, no. (%) | 60 (37) | 41 (29) | 0.17 |
| Readmissions, no. | 92 | 66 | 0.17 |
| Patients readmitted within 30 days, no. (%) | 27 (17) | 14 (10) | 0.10 |
| Mortality | |||
| Patients deceased, no. (%) | 21 (13) | 20 (14) | 0.72 |
DRP drug-related problems
aThe same person might have more than one type of drug-related readmission